Advances in CRISPR/Cas technology have revolutionized genome editing, offering unprecedented precision and efficiency in modifying genetic material. In our book, "Optimization of CRISPR/Cas Editing Efficiency in Non-Model Organisms," I explored the complexities of utilizing this powerful tool in research involving non-model organisms. From understanding the molecular machinery of the CRISPR/Cas system to overcoming barriers in delivery and enhancing homology-directed repair efficiency, each chapter offers a comprehensive exploration of key concepts and strategies. Additionally, I addressed the ethical and regulatory considerations inherent in genome editing, providing insights into the evolving regulatory landscape governing the use of CRISPR/Cas technology. Through evidence-based discussions and case studies, this book aims to guide researchers and policymakers in navigating the intricacies of CRISPR/Cas editing in non-model organisms, ultimately fostering responsible and impactful research practices.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
PAP. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bestandsnummer des Verkäufers L0-9798320215464
Anzahl: Mehr als 20 verfügbar
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes Königreich
Paperback. Zustand: New. Bestandsnummer des Verkäufers LU-9798320215464
Anzahl: Mehr als 20 verfügbar
Anbieter: CitiRetail, Stevenage, Vereinigtes Königreich
Paperback. Zustand: new. Paperback. Advances in CRISPR/Cas technology have revolutionized genome editing, offering unprecedented precision and efficiency in modifying genetic material. In our book, "Optimization of CRISPR/Cas Editing Efficiency in Non-Model Organisms," I explored the complexities of utilizing this powerful tool in research involving non-model organisms. From understanding the molecular machinery of the CRISPR/Cas system to overcoming barriers in delivery and enhancing homology-directed repair efficiency, each chapter offers a comprehensive exploration of key concepts and strategies. Additionally, I addressed the ethical and regulatory considerations inherent in genome editing, providing insights into the evolving regulatory landscape governing the use of CRISPR/Cas technology. Through evidence-based discussions and case studies, this book aims to guide researchers and policymakers in navigating the intricacies of CRISPR/Cas editing in non-model organisms, ultimately fostering responsible and impactful research practices. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Bestandsnummer des Verkäufers 9798320215464
Anzahl: 1 verfügbar
Anbieter: Rarewaves.com UK, London, Vereinigtes Königreich
Paperback. Zustand: New. Bestandsnummer des Verkäufers LU-9798320215464
Anzahl: Mehr als 20 verfügbar